Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SMAD6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
TTN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EDN3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KDM5D - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC284930 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
ALDH8A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF610 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TBX18 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC37A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARAP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM255B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OR1D2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IGK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATP1A2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NMT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on